Emmaus Life Sciences (EMMA) 10-Q2024 Q1 Quarterly report

Filed: 10 Sep 24, 1:15pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: Abbreviated, Absent, acknowledged, acquisition, aggregate, announced, avoid, background, backlog, began, borrowing, branded, cancellation, cessation, competing, counsel, default, department, derecognized, difficulty, employment, extended, familiarity, final, formal, fourth, fraudulent, fulfilling, gain, half, immaterial, imposition, incorrectly, independent, intellectual, interruption, introduction, JPY, KRW, lack, letter, light, maker, matter, meantime, order, organization, Ph, promise, properly, protection, reached, rebound, resolved, scheduled, shortage, staffed, standby, Steering, stockholder, surrender, surrendered, thinly, tracking, translation, troubled, unexpected, version, vet, volume, wholesale

Removed: abroad, accuracy, ACS, Addenda, affecting, approach, Asembia, bankruptcy, bifurcated, carry, Checklist, consultation, contemplated, curtail, dependence, designate, expand, impairment, Instrument, IP, launched, Lim, managed, measured, offered, operation, output, portal, pronouncement, recoverable, recovery, remotely, reserve, retained, Seah, solution, support, telehealth, thereon, Topic, unpaid, UpScript, VIE, voting, web

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

EMMA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of Emmaus Life Sciences, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the date indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Willis C. Lee
Willis C. Lee
Chief Executive Office
(Principal Executive Officer)
September 10, 2024

/s/ Yasushi Nagasaki
Yasushi Nagasaki
Chief Financial Officer
(Principal Financial and Accounting Officer)
September 10, 2024

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.